Skip to content
  • About
  • Contact
  • Our Staff
  • Advertise
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

FDA

Direct-to-Consumer Advertising Oversight: How FDA’s Crackdown Is Redefining Pharma Marketing
Posted in
  • Industry Landscape
  • Strategy & Execution

Direct-to-Consumer Advertising Oversight: How FDA’s Crackdown Is Redefining Pharma Marketing

The glossy world of pharmaceutical advertising is facing its biggest regulatory reset in two decades. For … Direct-to-Consumer Advertising Oversight: How FDA’s Crackdown Is Redefining Pharma MarketingRead more

by Gurinder Khera•October 4, 2025October 4, 2025•0
FDA Expands Crackdown on Deceptive DTC Ads with New Rulemaking: Closing the 1997 Loophole and Redefining Pharma Marketing
Posted in
  • Case Studies & Trends

FDA Expands Crackdown on Deceptive DTC Ads with New Rulemaking: Closing the 1997 Loophole and Redefining Pharma Marketing

The pharmaceutical industry has long relied on glossy direct-to-consumer (DTC) ads to shape patient behavior. From … FDA Expands Crackdown on Deceptive DTC Ads with New Rulemaking: Closing the 1997 Loophole and Redefining Pharma MarketingRead more

by Gurinder Khera•September 22, 2025September 22, 2025•0

Recent Posts

  • AI-Powered Territory Management for Pharma Sales Success in 2025
  • Optimizing ROI Measurement: Overcoming Market Access Challenges in Pharma Sales
  • Digital Transformation in Pharma: Powering Sales with Video Marketing Strategies
  • Personalized Marketing in Pharma: Key Tactics for 2025 Success
  • AI in Pharma Marketing: How AI in Pharma Marketing Is Revolutionizing HCP Engagement in 2025

Recent Comments

No comments to show.
Copyright © 2025 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A